Literature DB >> 9408697

Effect of initial slow graft function on renal allograft rejection and survival.

A Humar1, E M Johnson, W D Payne, L Wrenshall, D E Sutherland, J S Najarian, K J Gillingham, A J Matas.   

Abstract

Cadaver renal allografts with immediate excellent function have good long-term outcomes, while grafts with delayed function have been associated with an increased incidence of acute rejection (AR) and subsequent poor long-term graft survival. There is, however, an intermediate group with initial slow function whose outcome is not well defined. This group was examined by reviewing 510 patients that received primary cadaver transplants between 1/85 and 8/95. Recipients were grouped by initial function into: 1) those with immediate graft function (IGF), defined by serum creatinine (Cr) level < 3 mg/dl on post-operative day (POD) 5 (n = 237); 2) those with slow graft function (SGF), defined by serum Cr > 3 mg/dl on POD 5 but no need for dialysis (n = 160); and 3) those with delayed graft function (DGF), defined by the need for dialysis in the first week post-transplant (n = 113). Five-year graft survivals were determined for each group by Kaplan-Meier methods and compared by a generalized Wilcoxon test. The incidence of AR in the first 6 months was significantly higher in those with SGF (40%) vs. those with IGF (30%) (p < 0.05); both groups had a lower incidence than those with DGF (47%) (p < 0.05). In the absence of AR, 5-yr graft survival was similar between the 3 groups, 94%, 97% and 92% for IGF, SGF and DGF respectively. In the presence of AR, 5-yr graft survival was significantly reduced in all groups, but most notably in those with SGF (51%) or DGF (53%), as compared to those with IGF (80%), (p < 0.001). We conclude that recipients with SGF, but no AR, have excellent outcomes, comparable to those with IGF. However, there is an increased incidence of early AR associated with SGF. In recipients with SGF or DGF, AR has a more profound detrimental effect on long-term graft survival than in the IGF group. Thus, recipients with SGF are at increased risk for AR with resultant poor long-term graft survival, and may need modified immunosuppressive protocols.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9408697

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  20 in total

1.  Use of a Targeted Urine Proteome Assay (TUPA) to identify protein biomarkers of delayed recovery after kidney transplant.

Authors:  Kenneth R Williams; Christopher M Colangelo; Lin Hou; Lisa Chung; Justin M Belcher; Thomas Abbott; Isaac E Hall; Hongyu Zhao; Lloyd G Cantley; Chirag R Parikh
Journal:  Proteomics Clin Appl       Date:  2017-03-31       Impact factor: 3.494

2.  The effects of preoperative immunosuppressive therapy on ischemia and reperfusion (I/R) injury in healthy rats.

Authors:  Selcuk Kilinc; Sedat Tan; Efsun Hatice Kolatan; Dane Ruscuklu; Esra Satici; Mehmet Kemiksiz; Lutfi Dalkilic; Umut Eren Erdogdu; Cezmi Karaca
Journal:  Int Urol Nephrol       Date:  2013-09-08       Impact factor: 2.370

Review 3.  Delayed graft function in the kidney transplant.

Authors:  A Siedlecki; W Irish; D C Brennan
Journal:  Am J Transplant       Date:  2011-09-19       Impact factor: 8.086

4.  Implications of donor disseminated intravascular coagulation on kidney allograft recipients.

Authors:  Connie J Wang; Shahzad Shafique; Johanna McCullagh; Dennis A Diederich; Franz T Winklhofer; James B Wetmore
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-03       Impact factor: 8.237

5.  Clinical analysis of perioperative complement activity during ischemia/reperfusion injury following renal transplantation.

Authors:  Wojciech Błogowski; Barbara Dołęgowska; Daria Sałata; Marta Budkowska; Leszek Domański; Teresa Starzyńska
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-16       Impact factor: 8.237

6.  IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation.

Authors:  Isaac E Hall; Sri G Yarlagadda; Steven G Coca; Zhu Wang; Mona Doshi; Prasad Devarajan; Won K Han; Richard J Marcus; Chirag R Parikh
Journal:  J Am Soc Nephrol       Date:  2009-09-17       Impact factor: 10.121

7.  Five-year experience with donation after cardiac death kidney transplantation in a Canadian transplant program: Factors affecting outcomes.

Authors:  Michael Moser; Michael Sharpe; Corinne Weernink; Harrison Brown; Thomas McGregor; Andrew A House; Patrick P Luke
Journal:  Can Urol Assoc J       Date:  2012-12       Impact factor: 1.862

8.  Similar outcomes with different rates of delayed graft function may reflect center practice, not center performance.

Authors:  S K Akkina; J J Connaire; A K Israni; J J Snyder; A J Matas; B L Kasiske
Journal:  Am J Transplant       Date:  2009-05-20       Impact factor: 8.086

9.  Delayed graft function and the risk for death with a functioning graft.

Authors:  Shruti N Tapiawala; Kathryn J Tinckam; Carl J Cardella; Jeffrey Schiff; Daniel C Cattran; Edward H Cole; S Joseph Kim
Journal:  J Am Soc Nephrol       Date:  2009-10-29       Impact factor: 10.121

Review 10.  The pathogenesis and treatment of chronic allograft nephropathy.

Authors:  Can Li; Chul Woo Yang
Journal:  Nat Rev Nephrol       Date:  2009-07-28       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.